The Valvular Interventions Center

Filter Your Results




Data Presented From SURTAVI and NOTION Trials of TAVR

May 18, 2017 -- Findings from the randomized SURTAVI (Surgical Replacement and Transcatheter Aortic Valve Implantation) trial showed that patients at intermediate risk for sur…

Thirty-Day Outcomes Presented for Edwards' Centera TAVR Device

May 17, 2017 -- Edwards Lifesciences announced the first data on patients treated with the company's self-expanding Centera transcatheter aortic valve replacement (TA…

Medtronic's CoreValve and CoreValve Evolut R TAVR Systems Evaluated in Real-World Studies

May 16, 2017 -- Medtronic announced that new data on the company's self-expanding CoreValve platform were presented from the CoreValve ADVANCE and Evolut R FORWA…

One-Year REPRISE III Data Presented for Boston Scientific's Lotus TAVR System

May 16, 2017 -- Boston Scientific Corporation announced that results from the REPRISE III clinical trial were presented at the EuroPCR 2017 conference in Paris, France. A…

Boston Scientific Closes Symetis Acquisition

May 16, 2017 -- Boston Scientific Corporation announced the close of its acquisition of Symetis SA, a privately held Swiss structural heart company focused on transcatheter ao…

Real-World Use of Edwards' Sapien 3 TAVR System Evaluated in SOURCE 3 Registry Data

May 16, 2017 -- Edwards Lifesciences announced that new 1-year data from the SOURCE 3 Registry, a large European postapproval study of the company's Sapien 3 tra…

Millipede Announces Successful First Use of the Iris Complete Annuloplasty Ring

May 12, 2017 -- Millipede, Inc. announced that it has successfully completed its first clinical use of its transcatheter Iris complete annuloplasty ring. At the Italian Hospit…

BRAVO-3 Trial Shows Increased Risk of Early Stroke With New-Onset Atrial Fibrillation After TAVR

May 11, 2017 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced the presentation of data from the BRAVO-3 randomized trial showing that more than…



2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.